Genomatica is a U.S.-based industrial biotechnology company that develops and licenses commercial biomanufacturing processes to produce key intermediate chemicals from renewable feedstocks. Using engineered microorganisms and fermentation, it targets drop-in equivalents to petrochemical products, enabling lower-carbon supply chains without requiring changes to downstream manufacturing. The company serves markets across polymers, fibers, textiles, and personal care, and collaborates with chemical producers and brand owners to scale production.
Genomatica’s portfolio includes processes for widely used intermediates such as 1,4-butanediol (BDO) for engineering plastics and 1,3-butylene glycol for personal care formulations, as well as bio-based routes to nylon intermediates. Its technologies are designed for commercial-scale deployment through technology licensing, joint ventures, and offtake partnerships, aiming to reduce reliance on fossil resources while maintaining performance parity with conventional materials. Genomatica is headquartered in San Diego, California.
